TMC Life Sciences (0101.KU) - Malaysia
(2nd) quarter ended Dec 31:
Figures Are In Ringgit (MYR).
2025 2024
Revenue 103,497,000 80,426,000
PreTax Profit 9,336,000 -493,000
Net Profit 6,560,000 -947,000
Earnings Per Share 0.38 Sen -0.05 Sen
Dividend 0.00 Sen 0.00 Sen
6 months ended Dec 31:
Revenue 203,974,000 162,393,000
PreTax Profit 15,903,000 3,966,000
Net Profit 10,973,000 1,989,000
Earnings Per Share 0.63 Sen 0.11 Sen
Dividend 0.00 Sen 0.00 Sen
(END) Dow Jones Newswires
February 09, 2026 05:06 ET (10:06 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.